SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cardiome -- CRME
CRME 2.330-2.1%May 16 4:00 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (204)9/6/2007 3:54:35 PM
From: dr.praveen   of 285
 
"In light of the recent announcement of a panel meeting for i.v. vernakalant, and in advance of a major near-term event for oral vernakalant, Dundee Securities will be hosting an investor conference call with an atrial fibrillation (AF) expert on September 6, 2007 at 5pm EST. Dial in numbers: 800-769-8320 or 416-695-5259; Confirmation #: T648176D.

The expert, who is familiar with Cardiome's drug and the FDA Cardiorenal Division, will be discussing the clinical profile of i.v. vernakalant compared to marketed and development stage drugs, his perception of the current mindset of the FDA, and the opportunity for oral vernakalant."

Cheers,
Praveen
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News